Home Committees Demand F.D.A. Data on Alzheimer’s Drug Approval
Two powerful congressional committees investigating the controversial federal approval of Biogen's Alzheimer's drug Aduhelm requested extensive information and documents from the Food and Drug Administration in a letter published Thursday,…